Coronary Stent Thrombosis

Coronary Stent Thrombosis - most related articles:

- Prasugrel cuts risk of stent-related clots - 11.5
- Certain drug coated stents may be safe, effective - 8.9
- Stent design may put patients at risk of heart attack - 7.8
- FDA will review Daiichi Sankyo, Lilly drug Prasugrel for heart attack - 6.3
- Drug eluting stents prove more effective - 5.7
- Migraine linked to blood clots in veins, venous thrombosis - 5.6
- Coronary artery bypass graft surgeries decreasing in US - 5.2
- Benefits of anti clotting medications reduced by heartburn drugs - 4.2
- Stroke clinical trial finds intensive medical treatment better than brain stent - 4.2
- Effient to reduce heart attack risk in angioplasty patients - 3.7

Coronary Stent Thrombosis articles

Prasugrel cuts risk of stent-related clots
The investigational antiplatelet drug prasugrel plus aspirin produced a marked and highly statistically significant reduction in the risk of coronary stent thrombosis (ST) - a major concern for physicians and patients with potentially fatal consequences - in patients who received a stent as compared to standard therapy with clopidogrel (Plavix) plus aspirin, according to a stent analysis from the head-to-head TRITON-TIMI 38 trial.

1 Coronary Stent Thrombosis articles listed above.

List health news, Health organizations, Health news world, Glossary, Best health articles, Featured     Go to top

The information provided on Health Newstrack is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician. We comply with the HONcode principles for trustworthy health information, and Health News Track is hon code accredited, verify here.
About us, Site map Privacy policy, Disclaimer
© 2007, 2008, 2009, 2010, 2011 HealthNewsTrack.com
3.56